Medicare Enrolled

Dr. Gloria Ortiz, M.D.

Endocrinology · Mcallen, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1900 S JACKSON RD STE 1, Mcallen, TX 78503
9563404222
Registered in NPPES since 2010
NPI: 1871825307 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ortiz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ortiz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ortiz

Dr. Gloria Ortiz is an endocrinology specialist in Mcallen, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Ortiz performed 7,958 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Ortiz received a total of $535,936 from 38 pharmaceutical and/or device companies across 975 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ortiz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ Top 6% volume in TX $535,936 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
7,958
Medicare services
Top 6% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Remote vital sign monitoring management, each additional 20 minutes
This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period.
1,076 $31 $75
Denosumab injection (Prolia/Xgeva) 780 $19 $45
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
656 $37 $90
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
593 $86 $185
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
507 $37 $105
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
462 $8 $14
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
314 $9 $20
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
308 $16 $35
Free T3 thyroid hormone test
A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning.
303 $16 $35
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
258 $37 $100
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
250 $3 $10
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
242 $44 $105
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
214 $28 $60
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
205 $9 $20
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
141 $49 $100
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
140 $14 $30
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
136 $82 $200
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
126 $26 $55
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
109 $10 $24
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
107 $10 $30
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
106 $6 $10
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
106 $5 $10
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
89 $1 $5
Ultrasound elastography of first lesion
An ultrasound procedure used to measure the elasticity of the first identified growth or lesion.
80 $72 $165
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
78 $13 $25
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
69 $96 $250
Ultrasound elasticity scan, each additional growth
This procedure uses ultrasound to measure the elasticity of an additional growth. It is billed as an add-on service for each extra lesion assessed beyond the initial one.
62 $47 $105
Microsomal antibody test
A blood test that measures the level of microsomal antibodies, which are autoantibodies produced by the immune system.
61 $14 $25
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
61 $102 $215
Ultrasound of arm and leg arteries
This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries.
54 $54 $140
Fine needle aspirate evaluation
A laboratory examination of cells collected via fine needle aspiration to assess for abnormalities.
33 $41 $100
Additional Pap test evaluation episode
An additional immediate evaluation of a fine needle aspirate sample during a Pap test procedure.
33 $22 $55
Remote physiologic monitoring setup and education
Initial setup of remote monitoring equipment and patient education on its use.
31 $15 $35
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
30 $24 $90
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
25 $140 $250
Ultrasound scan of organ tissue for measuring elasticity
This procedure uses ultrasound technology to assess the stiffness or elasticity of organ tissues. It helps evaluate tissue characteristics without invasive methods.
24 $81 $175
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
24 $8 $15
New patient office visit, complex (60-74 min) 21 $159 $300
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
16 $102 $225
Total cortisol level test
A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands.
16 $16 $30
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $59 $125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$535,936
Total received (2018-2024)
Avg $76,562/year across 7 years
Top 5% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
975
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$69,088
2023
$61,654
2022
$110,744
2021
$116,448
2020
$43,500
2019
$66,987
2018
$67,516

Payments by company (2024)

Novo Nordisk Inc
$26,700
Bayer Healthcare Pharmaceuticals Inc.
$16,744
Lilly USA, LLC
$11,169
Boehringer Ingelheim Pharmaceuticals, Inc.
$9,430
Ascendis Pharma Inc
$4,220
Madrigal Pharmaceuticals
$150
Corcept Therapeutics
$146
Novartis Pharmaceuticals Corporation
$137
Medtronic, Inc.
$122
Dexcom, Inc.
$85
Tempus AI, Inc
$66
SANOFI-AVENTIS U.S. LLC
$63
BETA BIONICS, INC.
$25
Tandem Diabetes Care, Inc.
$15
Amgen Inc.
$15
Top 3 companies account for 79.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$216,326
Janssen Pharmaceuticals, Inc
$92,993
Boehringer Ingelheim Pharmaceuticals, Inc.
$68,114
Lilly USA, LLC
$43,162
SANOFI-AVENTIS U.S. LLC
$32,938
Bayer HealthCare Pharmaceuticals Inc.
$31,979
Bayer Healthcare Pharmaceuticals Inc.
$20,533
Xeris Pharmaceuticals, Inc.
$18,146
Ascendis Pharma Inc
$4,220
Rhythm Pharmaceuticals, Inc.
$3,386
Abbott Laboratories
$819
AstraZeneca Pharmaceuticals LP
$434
Senseonics, Incorporated
$400
Amgen Inc.
$279
Amarin Pharma Inc.
$278
Insulet Corporation
$201
Dexcom, Inc.
$191
Corcept Therapeutics
$166
Janssen Scientific Affairs, LLC
$163
Medtronic, Inc.
$153
Madrigal Pharmaceuticals
$150
MannKind Corporation
$138
Novartis Pharmaceuticals Corporation
$137
Intuitive Surgical, Inc.
$129
Tempus AI, Inc
$66
Alexion Pharmaceuticals, Inc.
$64
Medtronic MiniMed, Inc.
$49
Tandem Diabetes Care, Inc.
$49
DEXCOM, INC.
$49
Radius Health, Inc.
$43
Intuity Medical Inc
$37
Antares Pharma, Inc.
$33
BETA BIONICS, INC.
$25
Shire North American Group Inc
$23
Ipsen Biopharmaceuticals, Inc
$21
Regeneron Healthcare Solutions, Inc.
$16
IBSA Pharma Inc.
$14
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 70.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BYDUREON · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DISEASE STATE · Da Vinci Surgical System · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMULIN · INVOKAMET · INVOKANA · Imcivree · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · Levemir · MINIMED 780G · MOUNJARO · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · Omnipod · Otrexup · Ozempic · PRALUENT ALIROCUMAB INJECTION · Pogo Automatic Blood Glucose Monitoring System · Prolia · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · Saxenda · Somatuline Depot · Strensiq · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Mcallen?
Compare endocrinologists in the Mcallen area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
10
County median income
$52,281
Nearest hospital to ZIP centroid (approximate)
RIO GRANDE REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ortiz is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ortiz experienced with remote vital sign monitoring management, each additional 20 minutes?
Based on Medicare claims data, Dr. Ortiz performed 1,076 remote vital sign monitoring management, each additional 20 minutes services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ortiz receive payments from pharmaceutical companies?
Yes. Dr. Ortiz received a total of $535,936 from 38 companies across 975 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ortiz's costs compare to other endocrinologists in Mcallen?
Dr. Ortiz's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ortiz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →